http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Aurora Repurchases ~US$9.0 Million Principal Amount of Convertible Notes; Continues Progress Towards Positive Free Cash Flow with less than ~US$39 Million of Notes Outstanding
-
Aurora Expands Strains for Heroes Offerings Designed for Veterans, by Veterans
-
Aurora Cannabis (ACB) Partners with Herbarium to Expand CBD Portfolio into Brazil
-
Aurora Cannabis Partners with leading Brazilian company Herbarium to expand CBD Portfolio into Brazil
-
Aurora Cannabis Announces Results of 2023 Annual General Meeting
-
Aurora Cannabis Announces Fiscal 2024 First Quarter Results, and Delivers Record Positive Adjusted EBITDA
-
Aurora Launches Innovative Infused Pre-Rolls with 50%+ THC for Medical Cannabis Patients on AuroraMedical.com
-
Aurora Cannabis to Host First Quarter Fiscal Year 2024 Investor Conference Call
-
Aurora Cannabis (ACB) Announces Sale of Aurora Sun Facility to Bevo Expected to Provide Incremental Revenue and Cash Flow
-
Aurora Cannabis Announces Sale of Aurora Sun Facility to Bevo Expected to Provide Incremental Revenue and Cash Flow
-
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders
-
Aurora Cannabis Announces Fiscal 2023 Third Quarter and Files Full Year Results
-
Aurora Cannabis to Host Third Quarter and Fiscal Year 2023 Investor Conference Call and File Related Year End Information
-
Aurora Celebrates Summer with New Innovation Launching Across Canada
-
Aurora Expands Medical Cannabis Portfolio in Germany: New flower varieties for patients with high THC needs
-
Aurora Cannabis Partners with Strainprint to Empower Patients on their Cannabis Journey
-
Aurora Introduces Fresh Innovation for Spring
-
Aurora Cannabis (ACB) Buys Back $22M Principal Amount of Convertible Notes
-
Aurora Repurchases ~$22 Million Principal Amount of Convertible Notes, Saving $1.2 Million in Annualized Interest Payments and Leaving ~$79 Million (US$59) of Notes Outstanding; Balance Sheet Remains
-
Aurora Cannabis (ACB) and MedReleaf Australia Launch IndiMed Tempo 26, Further Strengthening Product Offerings for Medical Cannabis Patients
-
Aurora and MedReleaf Australia Launch IndiMed Tempo 26, Further Strengthening Product Offerings for Medical Cannabis Patients
-
Aurora Cannabis (ACB) Repurchases ~$47M Principal Amount of Convertible Notes
-
Aurora Repurchases ~$47 Million Principal Amount of Convertible Notes, Saving $2.6 Million in Annualized Interest Payments; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry
-
Aurora Cannabis (ACB) Provides Update on Nasdaq Listing
-
Aurora Provides Update on Nasdaq Listing
-
Aurora Launches New Medical Flower Product, Valour - Designed for Veterans, by Veterans
-
Aurora Cannabis (ACB) and MedReleaf Australia Launch CraftPlant
-
Aurora and MedReleaf Australia Launch new Medical Cannabis Brand - CraftPlant
-
Aurora Cannabis Announces Fiscal 2023 Second Quarter Results
-
Aurora Cannabis to Host Second Quarter Fiscal Year 2023 Investor Conference Call
-
Aurora Cannabis Announces Sale of Polaris Facility - Balance Sheet Remains Among Strongest in Industry
-
Aurora's Greybeard Brand Wins KIND Magazine's 'Best Diamonds of the Year' Award
-
Aurora Cannabis Repurchases ~$103 Million Principal Amount of Convertible Notes; Balance Sheet Among Strongest in Industry
-
Aurora Cannabis Announces Results of 2022 Annual General and Special Meeting
-
Aurora Cannabis Announces Fiscal 2023 First Quarter Results
-
Aurora Cannabis to Host First Quarter Fiscal Year 2023 Investor Conference Call
-
Aurora Cannabis Announces Mailing of Management Information Circular for the Annual and Special Meeting of Shareholders
-
Aurora Announces Unprecedented Fall Product Release Across Adult-Use and Medical Markets
-
Aurora Cannabis (ACB) Repurchases $23M Principal Amount of Convertible Notes
-
Aurora Cannabis Repurchases ~US$23 Million Principal Amount of Convertible Notes; Balance Sheet Among Strongest in Industry
-
Biden overhauls U.S. policy on marijuana, pardons prior federal offenses
-
Akanda Plans First Shipment of Medical Cannabis to Germany and Anticipates Leading Market Share Position
-
Aurora Cannabis Announces Fiscal 2022 Fourth Quarter and Full Year Results
-
Founder of Aurora Cannabis Terry Booth, Joins Akanda as Chair of Advisory Board
-
Aurora Cannabis to Host Fourth Quarter and Full Fiscal Year 2022 Investor Conference Call and Related Year End Informational Filings
-
Aurora Cannabis (ACB) Acquires Controlling Stake in Bevo Farms
-
Aurora Cannabis Acquires Controlling Interest in Bevo Farms
-
Aurora Cannabis (ACB) Granted EU-GMP Certification at Preeminent Local Cannabis Production Facility in Germany
-
Aurora Strengthens Leadership Position in Germany with EU-GMP Certification at Preeminent Local Cannabis Production Facility
-
Aurora Cannabis Announces Fiscal 2022 Third Quarter Results

